Autophagy: Cancer & Parkinson

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

August 2, 2020

Maysin plays a protective role against α-Synuclein oligomers cytotoxicity by triggering autophagy activation

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Manuela LeriDonatella Degl'Innocenti
August 6, 2020
Review
Open Access

Cancer Cachexia: Definition, Staging, and Emerging Treatments

Cancer Management and Research
Jun Ni, Li Zhang
August 3, 2020

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

International Review of Neurobiology
Michael F AlmeidaStephen T Kinsey
July 30, 2020
Review
Open Access

Ailanthone: A novel potential drug for treating human cancer

Oncology Letters
Haixiang DingZhilong Yan
August 4, 2020
Review
Open Access

The biological function of m6A demethylase ALKBH5 and its role in human disease

Cancer Cell International
Jinyan WangQuan'an Zhang
August 1, 2020
Review

Berberine: A novel therapeutic strategy for cancer

IUBMB Life
Parisa SamadiMehdi Yousefi
July 30, 2020

Biology, pathology, and therapeutic targeting of RAS

Advances in Cancer Research
J Matthew RhettJohn P O'Bryan
August 1, 2020

lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy

Molecular Therapy : the Journal of the American Society of Gene Therapy
Mingli HanHuaying Dong
July 30, 2020
Comment / Editorial
Open Access

Beth Levine in memoriam

Autophagy
July 30, 2020
Open Access

CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Lingyu ZhuLei Zong
July 30, 2020

Vascular mimicry: Triggers, molecular interactions and in vivo models

Advances in Cancer Research
Stephen L WechmanPaul B Fisher

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/autophagy-cancer-parkinson/69f99d7e-c613-4c9c-a5b5-f41dd130ec39